dc.contributor.author | Minarik, T | |
dc.contributor.author | Melemed, A | |
dc.contributor.author | Krejcy, K | |
dc.contributor.author | Fitzthum, E | |
dc.contributor.author | Hayden, A | |
dc.contributor.author | Kose, MF | |
dc.contributor.author | Sufliarsky, J | |
dc.contributor.author | Beslija, S | |
dc.contributor.author | Saip, P | |
dc.contributor.author | Tulunay, G | |
dc.date.accessioned | 2021-03-06T21:04:25Z | |
dc.date.available | 2021-03-06T21:04:25Z | |
dc.date.issued | 2005 | |
dc.identifier.citation | Kose M., Sufliarsky J., Beslija S., Saip P., Tulunay G., Krejcy K., Minarik T., Fitzthum E., Hayden A., Melemed A., "A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma", GYNECOLOGIC ONCOLOGY, cilt.96, ss.374-380, 2005 | |
dc.identifier.issn | 0090-8258 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_fd1dabac-ba53-4410-90c8-0e36e9a29fdc | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/165606 | |
dc.identifier.uri | https://doi.org/10.1016/j.ygyno.2004.10.011 | |
dc.description.abstract | Objectives. Gemcitabine and carboplatin each have demonstrated effectiveness without increased neurotoxicity in pretreated patients with ovarian cancer. We evaluated the efficacy and safety of gemcitabine plus carboplatin in patients with recurrent ovarian cancer in a multicenter phase II study. | |
dc.language.iso | eng | |
dc.subject | Onkoloji | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Kadın Hastalıkları ve Doğum | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Tıp | |
dc.subject | KADIN HASTALIKLARI & DOĞUM | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma | |
dc.type | Makale | |
dc.relation.journal | GYNECOLOGIC ONCOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 96 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 374 | |
dc.identifier.endpage | 380 | |
dc.contributor.firstauthorID | 174409 | |